Prescriber Compliance with a New Computerized Insulin Guideline for Noncritically III Adults

被引:7
作者
Clemens, Evan [1 ]
Cutler, Timothy [2 ,3 ]
Canaria, Janice [4 ]
Pandya, Komal [5 ]
Parker, Patricia [2 ,6 ,7 ,8 ]
机构
[1] Univ Calif San Francisco, Med Ctr, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA
[3] Univ Calif Davis, Experiential Program, Davis, CA 95616 USA
[4] Palomar Pomerado Hlth, Escondido, CA USA
[5] Univ Kentucky, Lexington, KY USA
[6] Univ Calif Davis, Inpatient Pharm Serv, Davis, CA 95616 USA
[7] Univ Calif Davis, Med Ctr, Davis, CA 95616 USA
[8] Univ Calif Davis, Sch Med, Davis, CA 95616 USA
关键词
computerized physician order entry; guideline compliance; insulin order set; GLYCEMIC CONTROL; GLUCOSE CONTROL; HYPERGLYCEMIA; INFECTION; MORTALITY; THERAPY; RISK; ICU;
D O I
10.1345/aph.1P169
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: In March 2008, the University of California, Davis Medical Center (UCDMC), implemented a guideline for the inpatient management of diabetes in noncritically ill adults. In accordance with national guidelines, all patients with type 2 diabetes are prescribed basal, nutritional, and correctional insulin. The guideline was added to the electronic medical record as a standardized physician order set in April 2008 and provider training on the insulin guideline occurred in May 2008. OBJECTIVE: To evaluate provider compliance with a new electronic standardized insulin order set in a hospital setting. METHODS: All patients with insulin orders admitted to the general internal medicine service between June 1, 2008, and November 1, 2008, were evaluated in this single-center retrospective chart review at UCDMC in Sacramento. Patients older than 18 years with a history of type 2 diabetes were included in the analysis. Insulin orders were categorized as preferred (followed the guideline) or nonpreferred regimens (did not follow all components of the guideline). RESULT'S: A total of 265 patients were identified during the study period. The preferred regimen was ordered in 82 (30.9%) of the evaluated patient admissions. Of the 183 (69.1%) nonpreferred regimens, more than half (54.6%) contained correctional insulin alone; 84.2% of patient admissions prescribed nonpreferred regimens lacked nutritional insulin. Average admission blood glucose readings were higher in the preferred versus nonpreferred regimen group (224.4 vs 164.8 mg/dL, p < 0.001). CONCLUSIONS: The preferred regimen was not prescribed for the majority of patients admitted with a history of type 2 diabetes, despite computerized decision support. Nutritional insulin was the most common missing component in the nonpreferred regimens. Baseline clinical factors, educational modalities, and guideline content may have influenced prescribing patterns.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 26 条
[1]  
*AACE ADA CONS STA, 2009, ENDOCR PRACT, V15, P1
[2]  
*AACE ADA TASK FOR, 2006, DIABETES, V12, P458
[3]  
[Anonymous], DIABETES CARE S1, DOI DOI 10.2337/DC08-S005
[4]  
[Anonymous], 2010, DIABETES CARE, V33 Suppl 1, pS4, DOI [10.2337/dc10-S004, DOI 10.2337/DC10-S004]
[5]   Impaired glucose metabolism predicts mortality after a myocardial infarction [J].
Bolk, J ;
van der Ploeg, T ;
Cornel, JH ;
Arnold, AER ;
Sepers, J ;
Umans, VAWM .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 79 (2-3) :207-214
[6]   Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients - A systematic overview [J].
Capes, SE ;
Hunt, D ;
Malmberg, K ;
Pathak, P ;
Gerstein, HC .
STROKE, 2001, 32 (10) :2426-2432
[7]   Intensive Insulin Protocol Implementation and Outcomes in the Medical and Surgical Wards at a Veterans Affairs Medical Center [J].
Chen, Helen J. ;
Steinke, Douglas T. ;
Karounos, Dennis G. ;
Lane, Matthew T. ;
Matson, Adrienne W. .
ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) :249-256
[8]   Intensive versus Conventional Glucose Control in Critically Ill Patients [J].
Finfer, S. ;
Blair, D. ;
Bellomo, R. ;
McArthur, C. ;
Mitchell, I. ;
Myburgh, J. ;
Norton, R. ;
Potter, J. ;
Chittock, D. ;
Dhingra, V. ;
Foster, D. ;
Cook, D. ;
Dodek, P. ;
Hebert, P. ;
Henderson, W. ;
Heyland, D. ;
McDonald, E. ;
Ronco, J. ;
Schweitzer, L. ;
Peto, R. ;
Sandercock, P. ;
Sprung, C. ;
Young, J. D. ;
Su, S. ;
Heritier, S. ;
Li, Q. ;
Bompoint, S. ;
Billot, L. ;
Crampton, L. ;
Darcy, F. ;
Jayne, K. ;
Kumarasinghe, V. ;
Little, L. ;
McEvoy, S. ;
MacMahon, S. ;
Pandey, S. ;
Ryan, S. ;
Shukla, R. ;
Vijayan, B. ;
Atherton, S. ;
Bell, J. ;
Hadfield, L. ;
Hourigan, C. ;
McArthur, C. ;
Newby, L. ;
Simmonds, C. ;
Buhr, H. ;
Eccleston, M. ;
McGuinness, S. ;
Parke, R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) :1283-1297
[9]  
Furnary Anthony P, 2006, Endocr Pract, V12 Suppl 3, P22
[10]  
Gavin JR, 1999, DIABETES CARE, V22, pS5